GLP3 RT is a research compound investigated for its activity at glucagon-like peptide receptor pathways. Preclinical research has explored its effects on pancreatic beta-cell function, insulin secretion modulation, and satiety signalling in cellular and animal models.
As a GLP receptor-targeting analogue, it represents a focus area of contemporary metabolic research, particularly in the context of adipose tissue regulation and energy homeostasis studies. Research with GLP receptor-targeting peptides continues to expand our mechanistic understanding of metabolic disorders at the molecular level, including the roles of incretin hormones in glucose homeostasis.
In vitro investigations have characterised its binding affinity and receptor selectivity profiles, contributing to structure-activity relationship studies within the GLP receptor family. It is supplied for qualified researchers investigating enteroendocrine and metabolic signalling pathways.
Format: Lyophilised powder | Purity: ≥99% by HPLC | For Research Use Only
